INFECTIOUS DISEASE TEAM

Case W. McNamara, PhD
Director, Infectious Disease
[email protected]
I have more than fourteen years of experience in drug discovery for neglected tropical diseases (NTDs), including contributions toward multiple clinical-stage antimalarial candidates. Since joining Calibr at Scripps Research in 2014, I have directed numerous and various drug discovery programs under funding from the Bill & Melinda Gates Foundation, ranging from parasites and worms to bacteria and viruses. The new investment from Wellcome Trust in Calibr to become an NTD Flagship will afford our team even greater opportunities to develop new medicines to improve global health.
LinkedIn
Director, Infectious Disease
[email protected]
I have more than fourteen years of experience in drug discovery for neglected tropical diseases (NTDs), including contributions toward multiple clinical-stage antimalarial candidates. Since joining Calibr at Scripps Research in 2014, I have directed numerous and various drug discovery programs under funding from the Bill & Melinda Gates Foundation, ranging from parasites and worms to bacteria and viruses. The new investment from Wellcome Trust in Calibr to become an NTD Flagship will afford our team even greater opportunities to develop new medicines to improve global health.